Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Morel

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
Joint Bone Spine|January 4, 2011
Rituximab in rheumatoid arthritis and the risk of malignancies: report from a French cohortSamy Slimani, Cédric Lukas, Bernard Combe, et al.
Therapie|January 8, 2019
Alain Dutilleul, Jacques Morel, Clémentine Schilte, et al.
Arthritis Research & Therapy|April 28, 2020
Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohortGisèle Khoury, Jacques Morel, Bernard Combe, et al.
Arthritis Care & Research|December 17, 2013
Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysisCharlotte Hua, Thomas Barnetche, Bernard Combe, et al.
Joint Bone Spine|June 26, 2014
Reply to Talarico et al.'s comment: "Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study"Helene Che, Cedric Lukas, Jacques Morel, et al.
Rheumatology (Oxford, England)|December 1, 2021
Toward a holistic management of skin and joint disorders in PsA patientsAurélie Du-Thanh, Céline Girard, Jacques Morel, et al.
Cytokine|November 30, 2010
Lymphotoxin α stimulates proliferation and pro-inflammatory cytokine secretion of rheumatoid arthritis synovial fibroblastsFlavia Calmon-Hamaty, Bernard Combe, Michael Hahne, et al.
Arthritis Research & Therapy|August 25, 2011
Lymphotoxin α revisited: general features and implications in rheumatoid arthritisFlavia Calmon-Hamaty, Bernard Combe, Michael Hahne, et al.
Joint Bone Spine|May 16, 2021
Practical management of patients on anti-TNF therapy - the CRI guidelinesJérémie Sellam, Jacques Morel, Anne Tournadre, et al.
The Journal of Rheumatology|November 3, 2015
Association of Body Mass Index Categories with Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis: A Systematic Review and MetaanalysisCeline Vidal, Thomas Barnetche, Jacques Morel, et al.
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Joint Bone Spine|January 4, 2011
Rituximab in rheumatoid arthritis and the risk of malignancies: report from a French cohortSamy Slimani, Cédric Lukas, Bernard Combe, et al.
Therapie|January 8, 2019
Alain Dutilleul, Jacques Morel, Clémentine Schilte, et al.
Arthritis Research & Therapy|April 28, 2020
Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohortGisèle Khoury, Jacques Morel, Bernard Combe, et al.
Arthritis Care & Research|December 17, 2013
Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysisCharlotte Hua, Thomas Barnetche, Bernard Combe, et al.
Joint Bone Spine|June 26, 2014
Reply to Talarico et al.'s comment: "Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study"Helene Che, Cedric Lukas, Jacques Morel, et al.
Rheumatology (Oxford, England)|December 1, 2021
Toward a holistic management of skin and joint disorders in PsA patientsAurélie Du-Thanh, Céline Girard, Jacques Morel, et al.
Cytokine|November 30, 2010
Lymphotoxin α stimulates proliferation and pro-inflammatory cytokine secretion of rheumatoid arthritis synovial fibroblastsFlavia Calmon-Hamaty, Bernard Combe, Michael Hahne, et al.
Arthritis Research & Therapy|August 25, 2011
Lymphotoxin α revisited: general features and implications in rheumatoid arthritisFlavia Calmon-Hamaty, Bernard Combe, Michael Hahne, et al.
Joint Bone Spine|May 16, 2021
Practical management of patients on anti-TNF therapy - the CRI guidelinesJérémie Sellam, Jacques Morel, Anne Tournadre, et al.
The Journal of Rheumatology|November 3, 2015
Association of Body Mass Index Categories with Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis: A Systematic Review and MetaanalysisCeline Vidal, Thomas Barnetche, Jacques Morel, et al.
Pageof 20